- Baby Non-Food Products
- Baking/Cooking Staples
- Household Products
- Kitchen Products
- Paper Products
- Personal Care
- Pet Products
- RESEARCH & AWARDS
In addition to expanding its line of generic equivalents to Allegra, Prevacid and Mucinex, the company also plans to build additional partnerships in
“The Perrigo team has a strong business development pipeline and plans to expand our geographic footprint. We are looking for additional partners in
Rapid expansion is also taking place in the infant formula market. “Birthrates in the
Perrigo’s net earnings for the quarter fell to $70.4 million, down 4.3 percent from earnings of $73.4 million in the same quarter last year. The Allegan, Mi.-based company anticipates stronger earnings for the remainder of its 2012 fiscal year.
Sales for the quarter finished at $725.3 million, up 13 percent from $630.75 million in the same period last year. Sales also are anticipated to grow as the 2012 fiscal year progresses.